Atlas Trials

Study to Nivolumab Following Preoperative Chemoradiotherapy

Clinical trial NCT02948348 · UNKNOWN

Trial details

NCT number
NCT02948348
Sponsor
Takayuki Yoshino
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer of Rectum
Start date
2016-10-01
Primary completion
2021-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.